Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
11/20/2002 | CN1380318A A polypeptide-base mismatching correction protein-11.22 and polynucleotide for coding this polypeptide |
11/20/2002 | CN1380317A A polypeptide-ribosomal protein SII-11.99 and polynucleotide for coding this polypeptide |
11/20/2002 | CN1380316A A polypeptide-transducin subunit-15.84 and polynucleotide for coding this polypeptide |
11/20/2002 | CN1380315A A polypeptide-phytochrome protein-9.35 and polynucleotide for coding this polypeptide |
11/20/2002 | CN1380314A A polypeptide-guanine deoxynucleosidase activator protien-13.20 and polynucleotide for coding this polypeptide |
11/20/2002 | CN1380313A A polypeptide-ZP1 receptor protein -37.95 and polynucleotide for coding this polypeptide |
11/20/2002 | CN1380311A A polypeptide-histone H3-9.35 and polynucleotide for coding this polypeptide |
11/20/2002 | CN1380310A A polypeptide-ring finger protein-24.20 and polynucleotide for coding this polypeptide |
11/20/2002 | CN1380309A A polypeptide-high mobility component protein familia-11.44 and polynucleotide for coding this polypeptide |
11/20/2002 | CN1380308A A polypeptide-gap junction protein-12.21 and polynucleotide for coding this polypeptide |
11/20/2002 | CN1380307A A polypeptide-ribosomal protein -9.57 and polynucleotide for coding said polypeptide |
11/20/2002 | CN1380306A A polypeptide-uteroglobin-10.02 and polynucleotide for coding this polypeptide |
11/20/2002 | CN1380305A A polypeptide-air bubble protein -9.02 and polynucleotide for coding this polypeptide |
11/20/2002 | CN1380303A A novel polypeptide-human retinoblastoma binding protein 34.54 and polynucleotide for coding this polypeptide |
11/19/2002 | US6483010 DNA molecules encoding enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing these molecules |
11/19/2002 | US6482935 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
11/19/2002 | US6482934 Methods and compositions for detecting and treating kidney diseases associated with adhesion of crystals to kidney cells |
11/19/2002 | US6482929 Antibodies to ARF-p19 |
11/19/2002 | US6482928 Fab′-epitope complex from HIV-1 cross-neutralizing monoclonal antibody 2F5 |
11/19/2002 | US6482927 Chimeric proteins comprising the extracellular domain of murine Ob receptor |
11/19/2002 | US6482926 Antibody compositions for preparing enriched cell preparations |
11/19/2002 | US6482924 Leptospira vaccine antigens for the prevention of Leptospirosis |
11/19/2002 | US6482919 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
11/19/2002 | US6482624 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
11/19/2002 | US6482623 Lipid kinase |
11/19/2002 | US6482618 Self-enhancing, pharmacologically controllable expression systems |
11/19/2002 | US6482612 Adipocyte-specific protein homologs |
11/19/2002 | US6482605 Protein tyrosine phosphatase PTP20 and related products and methods |
11/19/2002 | US6482599 Forms of prostate specific antigen (PSA) specific for benign prostatic hyperplasia (BPH) and methods of using such |
11/19/2002 | US6482598 Antibody recognizing a small subset of human hematopoietic cells |
11/19/2002 | US6482596 Method for measuring antigen concentration |
11/19/2002 | US6482411 Osteoporosis |
11/19/2002 | US6482410 Mediation of neuronal attachment and enhancement of the outgrowth of neutites |
11/19/2002 | US6482409 Treatment for inflammatory bowel disease with a vcam-1/1gG fusion protein |
11/19/2002 | US6482408 Fibroblast growth factor 15 antibodies |
11/19/2002 | US6482403 Caniney IL-13 immunoregulatory proteins and uses thereof |
11/19/2002 | US6481360 Ultra fine fly ash and a system for collecting the same |
11/19/2002 | CA2312667C Novel cytokine |
11/19/2002 | CA2261579C Isolated peptides derived from mage-2 |
11/19/2002 | CA1341399C Intercellular adhesion molecules and their binding ligands |
11/18/2002 | CA2385735A1 A method of selecting an antibody, a hybridoma, a monoclonal antibody and use thereof |
11/14/2002 | WO2002092769A2 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication |
11/14/2002 | WO2002091212A2 Modular personal device system |
11/14/2002 | WO2002090986A1 Colon cancer antigen panel |
11/14/2002 | WO2002090974A2 Method for detecting progredient chronic dementia, and associated peptides and detection reagents |
11/14/2002 | WO2002090932A2 Methods and reagents for identifying insulin response modulators and therapeutic uses therefor |
11/14/2002 | WO2002090570A2 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression |
11/14/2002 | WO2002090566A2 Recombinant tumor specific antibody and use thereof |
11/14/2002 | WO2002090549A2 Compositions and methods for the modulation of viral maturation |
11/14/2002 | WO2002090542A2 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
11/14/2002 | WO2002090532A1 Novel mutation |
11/14/2002 | WO2002090530A2 Kinases and phosphatases |
11/14/2002 | WO2002090524A2 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof |
11/14/2002 | WO2002090520A2 Toll/interleukin-1 receptor adaptor protein (tirap) |
11/14/2002 | WO2002090508A2 Cell adhesion-mediating proteins and polynucleotides encoding them |
11/14/2002 | WO2002090504A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
11/14/2002 | WO2002090502A2 Highly conserved proteins from gram-positive bacteria |
11/14/2002 | WO2002090499A2 ss-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME |
11/14/2002 | WO2002090389A1 Monoclonal antibody for nkx3.1 and method for detecting same |
11/14/2002 | WO2002090387A1 Reproductive cancer diagnosis and therapy |
11/14/2002 | WO2002089843A1 Methods for treating or preventing cardiovascular disorders by modulating metalloprotease function |
11/14/2002 | WO2002089842A1 Combination therapy using anti-egfr antibodies and anti-hormonal agents |
11/14/2002 | WO2002089841A2 Method of preventing cell death using antibodies to neural thread proteins |
11/14/2002 | WO2002089837A1 Chimeric human leukocyte antigen and epitope-bearing molecules having immunosuppressant activity |
11/14/2002 | WO2002089836A1 Cancer metastasis interfering vaccine |
11/14/2002 | WO2002089747A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
11/14/2002 | WO2002089746A2 Hematopoietic stem cell chimerism to treat autoimmune disease |
11/14/2002 | WO2002089615A2 Anti-ige antibody to treat ocular allergies |
11/14/2002 | WO2002074904A3 Rearranged squamous cell carcinoma antigen genes ii |
11/14/2002 | WO2002074326A3 Urocortin-iii and uses thereof |
11/14/2002 | WO2002072605A3 Expression technology for proteins containing a hybrid isotype antibody moiety |
11/14/2002 | WO2002061081A9 A novel gene bn01 mapping to chromosome 16q24.3 |
11/14/2002 | WO2002046455A3 Process for selecting anti-angiogenesis antibody fragments, anti-angiogenesis antibody fragments thus obtained and their use |
11/14/2002 | WO2002032944A3 Basb208 nucleotide and amino acid sequences from haemophilus influenzae |
11/14/2002 | WO2002016440A8 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections |
11/14/2002 | WO2001019842A9 Subunit optimized fusion proteins |
11/14/2002 | US20020169303 Novel PTP-20, PCP-2, BDP1, CLK, and SIRP proteins and related products and methods |
11/14/2002 | US20020169301 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cell proliferative disorders |
11/14/2002 | US20020169288 Therapeutic composition for treating or preventing staphylococcal infection |
11/14/2002 | US20020169287 Nucleotide sequences coding polypeptide for use in the treatment of eating, dieteticad energy disorders |
11/14/2002 | US20020169286 Peptide for use in the detection and prevention of epstein barr infections |
11/14/2002 | US20020169284 Nucleotide sequences coding polypeptide for use in the treatment of tumors, nervous system, virus, and visoin disorders |
11/14/2002 | US20020169280 Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation |
11/14/2002 | US20020169264 Acylation with an acryloyl group of an amino group at some point in the peptide sequence, while still attached to the solid phase support with side chain groups intact, followed by deprotecting and free radical polymerization; vaccines |
11/14/2002 | US20020169132 Polypeptides |
11/14/2002 | US20020169127 Compositions and methods for diagnosing or treating psoriasis |
11/14/2002 | US20020169117 (RANK); RANK is a member of the TNF superfamily; used to regulate an immune response |
11/14/2002 | US20020169110 Diagnosis of metastatic cancer by the mts-1 gene |
11/14/2002 | US20020169106 Administering an OB-cadherin CAR (cell adhesion recognition) sequence |
11/14/2002 | US20020168754 Nucleotide sequences coding polypeptides for use in the treatment of gastric, testicular, retinal, nervous system and immunological disorders |
11/14/2002 | US20020168748 Polypeptide for use in the diagnosis, prevention and treatment of fungal infections |
11/14/2002 | US20020168740 Kinase for use in the treatment of inflammation, viral infection, cancer, sepsis, psoriasis and restenosis |
11/14/2002 | US20020168736 Nucleotide sequences coding protein for use in the treatment of immunological disorders |
11/14/2002 | US20020168735 Protein for use in the prevention of fungal infection |
11/14/2002 | US20020168724 Nucleotide sequences coding polypeptide for use in the treatment of ataxia, alzheimer's, parkinson's, learning defects, nervous system, epilepsy and stroke disorders |
11/14/2002 | US20020168722 Adjusted fibrinogen for use in the treatment blood clotting disorders |
11/14/2002 | US20020168719 Nucleotide sequences coding proteins for use in the treatment autoimmune and immunological diseases |
11/14/2002 | US20020168717 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of prostate cancer |
11/14/2002 | US20020168716 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of tumors, immunological, autoimmune, skin, viral, bone, nervous system and inflammatory disorders |
11/14/2002 | US20020168715 Secreted and transmembrane polypeptides and nucleic acids encoding the same |